Regeneron Pharmaceuticals, Inc. (REGN)
Market Closed
10 Aug, 20:00
$
808. 05
+23.69
+3.0203%
$
83.25B Market Cap
24.52 P/E Ratio
0.22% Div Yield
981,832 Volume
42.79 Eps
$ 784.36
Previous Close 
Want to track REGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 10.48 | - |
| | | - | - |
| | | 8.53 | 12.89 |
| | | - | - |
| | | 11.38 | 12.07 |
| | | 11.69 | 12.46 |
| | | 10.61 | 11.56 |
| | | 10.09 | 9.55 |
| | | 10.73 | 11.86 |
| | | 10.72 | 11.59 |
| | | 2.71 | 3.13 |
| | | 2.65 | 2.82 |
| | | 2.58 | 2.57 |
| | | 3.36 | 2.83 |
| | | 3.2 | 3.47 |
| | | 2.77 | 2.89 |
| | | 2.68 | 2.88 |
| | | 2.82 | 2.79 |
| | | 2.57 | 2.52 |
| | | 2.29 | 2.47 |
| | | 2.2 | 2.26 |
| | | 0.98 | 0.86 |
| | | 0.9 | 1.25 |
| | | 0.88 | 0.79 |
| | | 0.98 | 0.9 |
| | | 1.1 | 1.22 |
REGN Earnings Reports FAQ
What is the earnings per share (EPS) for REGN?
The current EPS is 42.79.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 21.71%, reflecting the REGN's performance and NASDAQ (NGS) market conditions.
When is the next earnings release date?
Regeneron Pharmaceuticals, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Regeneron Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for REGN at this time, as Regeneron Pharmaceuticals, Inc has no recent EPS data to calculate it.
